Navigation Links
Micell Technologies Receives CE Mark Approval for MiStent SES
Date:6/12/2013

DURHAM, N.C., June 12, 2013 /PRNewswire/ -- Micell Technologies, Inc. received CE (Conformite Europeenne) Mark approval for its MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES®) introducing a thin-strut stent that features elimination of the coating from the stent in 45-60 days and the complete absorption of the polymer coating within 90 days.  The MiStent SES is unique in providing local drug delivery both during and after the period of polymer absorption, thereby eliminating long-term polymer exposure, a potential cause of delayed healing and late adverse events.

Micell's Chief Executive Officer, Arthur J. Benvenuto, commented, "The MiStent SES brings a new paradigm of safety without compromise to efficacy or deliverability. With polymer absorption faster than any other DES currently available, we believe the MiStent SES provides a long-term safety profile of a highly deliverable bare metal stent."

The MiStent SES approval is supported by in-depth clinical analysis from the DESSOLVE I and DESSOLVE II clinical trials. The DESSOLVE II trial met its primary end point: superiority of MiStent SES in minimizing in-stent late lumen loss (LLL) at nine months as compared to Medtronic's Endeavor® Sprint DES (p<0.001). The trial was a randomized, multi-center study of 184 patients with documented stable or unstable angina pectoris. At nine months' follow-up, in-stent LLL was 0.27 mm with a target lesion revascularization rate of 0.9%. The major adverse cardiac events (MACE) rates were 4.3% for MiStent SES and 6.7% for Endeavor. In a sub-group of patients, optical coherence tomography (OCT) and endothelial function testing confirmed good vessel healing with excellent strut coverage and normal endothelial function.

The DESSOLVE I first-in-human study provides additional evidence for the potential clinical advant
'/>"/>

SOURCE Micell Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Micell Technologies Announces Issuance of Core Technology Patent
2. Development of New Technologies Spurs Molecular Diagnostic Test Volumes in Asia-Pacific, Finds Frost & Sullivan
3. Frost & Sullivan Market Share Leadership Award Highlights Acuo Technologies Accomplishments in Enterprise Imaging Informatics
4. Finalists Announced for Israel Brain Technologies Million Dollar Global B.R.A.I.N. Prize
5. Breathe Technologies Sleep System Receives FDA Clearance
6. BioSpecifics Technologies Corp. to Present at Jefferies 2013 Global Healthcare Conference
7. Israel Brain Technologies Announces Israels 1st International Brain Technology Conference
8. Global Markets and Technologies for Optical Coherence Tomography (OCT)
9. Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio
10. Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria
11. Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... BURLINGTON, Mass. , Aug. 21, 2014 /PRNewswire/ ... of COPD,  physicians in Brazil ... to follow clinical guidelines and commonly prescribe long-acting ... regimens, although they do so within current severe ... combinations (FDCs) that are expected to launch in ...
(Date:8/21/2014)... , N.Y. and HAMBURG, Germany , Aug. ... it is collaborating with Deutsches Elektronen-Synchrotron ( DESY ), ... , to speed up management and storage of ... Data and Analytics architecture based on IBM software ... second of data at peak performance and help scientists ...
(Date:8/21/2014)... percent of Americans believe the abuse of strong prescription pain ... safety issue in the United States , ... & Partners, a Cincinnati based research ... the prescription medication abuse problem and the need for medical ... facing our country," Rex Repass , CEO of the ...
Breaking Medicine Technology:Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3
... ASHBURN, Va., Dec. 18 Innocoll, Inc., ... first of three planned,phase 2 clinical trials ... Ltd, to investigate CollaRx(R) GENTAMICIN TOPICAL for ... ulcers, has commenced,dosing., CollaRx GENTAMICIN TOPICAL ...
... RICHMOND, Va., Dec. 18 Insmed Inc. (Nasdaq:,INSM), ... that the Food and Drug Administration (FDA) has ... of Myotonic Muscular,Dystrophy (MMD). Insmed is currently conducting ... MMD, and recently was awarded a grant of,approximately ...
Cached Medicine Technology:Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers 4Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy 2Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy 3
(Date:8/21/2014)... Researchers have pinpointed the environmental source of fungal infections ... for decades. It literally grows on trees. , The ... 13-year-old girl, who spent the summer gathering soil and ... by infections of the fungus named Cryptococcus gattii ... which encompasses a number of species including C. ...
(Date:8/21/2014)... Aug. 21, 2014 (HealthDay News) -- Black mothers are ... and here,s one possible reason why: Hospitals in neighborhoods ... than those in areas with more white residents, a ... breast-feeding are much less common in medical centers where ... the U.S. Centers for Disease Control and Prevention reported ...
(Date:8/21/2014)... seniors, dimming vision may be tied to poorer survival, new ... aged 65 to 84, who were assessed when they enrolled ... later. Vision loss over time was associated with an ... period, the researchers reported. Although the study couldn,t prove ... University in West Lafayette, Ind., offered up some theories on ...
(Date:8/21/2014)... New York (PRWEB) August 21, 2014 ... against C.R. Bard, Inc. continue to move forward ... District Court, Southern District of West Virginia, Bernstein ... issued on August 14th, the Court has established ... that requires special handling, division, storage and preservation. ...
(Date:8/21/2014)... woman is to focus on her body in terms ... viewing her as a complete human being with thoughts ... problem in the media, how does it affect individual ... Women Quarterly , a SAGE journal, finds that more ... higher incidents of sexual pressure and coercion., Researchers Laura ...
Breaking Medicine News(10 mins):Health News:Fungus deadly to AIDS patients found to grow on trees 2Health News:Racial Disparities in Breast-Feeding May Start With Hospitals, Study Suggests 2Health News:Failing Vision Tied to Shorter Lifespans for Seniors 2Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 3Health News:Objectification in romantic relationships related to sexual pressure and coercion 2
... oldest and largest,consumer organization dedicated to preventing vaccine ... announced today that it,will launch a national public ... informed, voluntary decisions about vaccination in America., ... of vaccines recommended by,federal officials for children during ...
... twice as likely to suffer major trauma; more education, ... -- Knee injuries are the most common reason for ... on nine high school sports at 100 U.S. high ... basketball, baseball and wrestling, and girls, soccer, volleyball, basketball ...
... Medicare premiums have doubled since 2000, AUSTIN, ... AARP members and volunteers today delivered more than,20,000 ... Hutchison and John,Cornyn in Dallas and Austin, saying ... increases., (Logo: http://www.newscom.com/cgi-bin/prnh/20030514/AARPLOGO ), ...
... Outreach, LAKE SUCCESS, N.Y., May 29 IPRO, ... the quality,of health care, announced today that it has ... on Google will link users,with IPRO,s consumer-directed sites., ... help us,enormously in our efforts to make health care ...
... Condensing the sum of oncology know-how presented at ... Conference presents a great opportunity to benefit from ... in oncology presented by renowned professionals in the ... continuing medical education, professional development and clinical experience ...
... The Little Clinic, CINCINNATI and NASHVILLE, Tenn., May ... The Little Clinic LLC today announced a,partnership aimed at ... across the country. Kroger has made a significant,investment in ... Financial terms of the investment were not disclosed. The ...
Cached Medicine News:Health News:NVIC Launches 'Stand Up Be Counted Campaign' to Protect Voluntary Vaccination Decisions in America 2Health News:NVIC Launches 'Stand Up Be Counted Campaign' to Protect Voluntary Vaccination Decisions in America 3Health News:Knee Injuries Main Cause of HS Sports Surgeries 2Health News:AARP Protests Medicare Premium Increases, Delivering Over 20,000 Petitions to Senators Hutchison and Cornyn 2Health News:AARP Protests Medicare Premium Increases, Delivering Over 20,000 Petitions to Senators Hutchison and Cornyn 3Health News:IPRO Receives Google Advertising Grant 2Health News:ESMO Conference Lugano 2Health News:Kroger and The Little Clinic Establish Partnership to Offer Customers Convenient Healthcare Centers Inside Their Neighborhood Store 2Health News:Kroger and The Little Clinic Establish Partnership to Offer Customers Convenient Healthcare Centers Inside Their Neighborhood Store 3
... The Carriazo-Pendular microkeratome is based on ... the cornea during the cut., ,This ... evenly from the beginning of the ... that the intraocular pressure does not ...
... somatomedin-C, is a peptide highly dependent on ... activity. IGF-I is transported in serum by ... growth disorders, measurements of IGF-I are a ... secretion. A normal plasma or serum IGF-I ...
... The IDS OCTEIATM IGF-I kit is a ... Insulin-like Growth Factor-I (IGF-I) in serum or ... polyclonal "capture" antibody in microtiter wells and ... horseradish peroxidase. A simple sample pre-treatment replaces ...
Inquire...
Medicine Products: